Hip Reconstruction Devices Market is growing at a CAGR of 4.9% to reach US$ 11,695.70 Million by 2033 from US$ 7,636.32 Million in 2024 by Product Type, Fixation Type, Material Type, Implant Component.

As per the latest market research by Business Market Insights (BMI), the research report" Hip Reconstruction Devices Market Size and Forecast (2025–2033)" forecasts how the market is set to surge 69.25% by 2033. The global hip reconstruction devices market is driven by the rising prevalence of osteoarthritis, hip fractures, and an aging population seeking improved mobility. Advances in implant design, 3D printing, and minimally invasive techniques enhance surgical outcomes. Growing adoption of robotic-assisted procedures and expanding healthcare access further fuel market growth worldwide.

The report forecasts the market to expand from US$ 7,636.32 million in 2024 to US$ 11,695.70 million by 2033, registering a robust CAGR of 4.9% over the 2025–2033 period.

The global hip reconstruction devices market is experiencing significant growth with factors such as growing prevalence of osteoarthritis, growing hip disorders, increasing percentage of elderly people, and increased awareness of hip replacement procedures. Rising cases of hip fractures and degenerative diseases commonly heightened the demand for primary and secondary hip replacement procedures. Advances in technology (including 3D-printing, computer-assisted surgery and robotic-assisted surgery) are resulting in improved precision and patient health outcomes. Additionally, growing adoption of minimally invasive techniques and improved biomaterials enhances recovery rates and patient satisfaction. The expansion of healthcare infrastructure and reimbursement in emerging economies also supports procedural growth. To summarize, as the awareness among patient increases, the demand for surgical solution also increases, thus, driving market growth.

Hip Reconstruction Devices Market

Overview of report findings

• Market Growth

The hip reconstruction devices market is projected to grow from US$ 7,636.32 million in 2024 to US$ 11,695.70 million by 2033, registering a compound annual growth rate (CAGR) of 4.9% between 2025 and 2033.

The global hip reconstruction devices market is driven by the rising prevalence of osteoarthritis, hip fractures, and an aging population seeking improved mobility. Advances in implant design, 3D printing, and minimally invasive techniques enhance surgical outcomes. Growing adoption of robotic-assisted procedures and expanding healthcare access further fuel market growth worldwide.

• Rising Prevalence of Osteoarthritis & Hip Fractures

The rising incidence of osteoarthritis and hip fractures is one of the largest contributors to the hip reconstruction devices market. Osteoarthritis is one of the most common joint diseases that is associated with acute pain and less mobility, especially in older or obese patients. Aging demographics, sedentary lifestyles, and rising obesity rates contribute significantly to the growing burden of hip degeneration. Moreover, rising cases of hip fracture mostly due to low bone density and accidental falls has also increased demand for hip replacement procedures. Patients seek to regain mobility and improve quality of life, leading to an ongoing rise in the number of hip reconstruction surgeries in healthcare facilities globally.

• Technological Advances in Implants and Techniques

Technological innovation plays a crucial role in driving the hip reconstruction devices market. For instance, advanced implant configurations such as modular, porous-coated, and 3D-printed implants provide better fixation, biocompatibility, and durability. Minimally invasive and computer-assisted surgical methods make it possible to achieve exact alignment, quicker recovery, and lesser postoperative complications. The use of robotics and navigation systems is becoming more popular, and this is resulting in greater surgical accuracy and consistency, which in turn leads to better patient outcomes and increased surgeon confidence. Besides, new materials like highly cross-linked polyethylene and ceramic composites reduce wear and implant failure rates. These improvements lead to higher patient satisfaction levels, encourage earlier surgical intervention, thus, supports market growth even ‍​‌‍​‍‌further.

• Geographic Insights

North America dominates the hip reconstruction devices market, due​‍​‌‍​‍‌​‍​‌‍​‍‌ to a high osteoarthritis prevalence, an advanced healthcare infrastructure, and a wide spread adoption of robotic-assisted surgeries. The regional market leadership is additionally supported by strong reimbursement systems and the presence of leading device manufacturers.

Europe is the second-largest market mainly because of its aging population, technological advancements in joint replacement, and increasing demand for minimally invasive procedures. The market growth is supported by favorable reimbursement policies and by the awareness of early treatment for hip disorders in the major countries.

The Asia Pacific is the fastest developing market, as healthcare investments continue to rise, the medical infrastructure is expanding, and the elderly population is growing. The regional market growth is due to the increasing obesity rates, the improved access to orthopedic care, and the strong adoption of advanced ​‍​‌‍​‍‌​‍​‌‍​‍‌implants.

Market Segmentation

• By product type, the hip reconstruction devices market is segmented into total hip implants, partial hip implants and revision hip implants. The total hip implants segment dominated the market in 2024.
• By fixation type, the hip reconstruction devices market is segmented into cemented, cementless, and hybrid. The cementless segment dominated the market in 2024.
• By material type, the market is segmented into metal, ceramic and polymer. The ceramic segment dominated the market in 2024.
• By implant component, the market is segmented into femoral stem & head and acetabular cup & liner. The femoral stem & head segment dominated the market in 2024.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, and orthopedic clinics. The hospitals segment held the largest share of the market in 2024.

Competitive Strategy & Development

• Key Players: The hip reconstruction devices market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Stryker
2. Zimmer Biomet
3. Johnson & Johnson
4. Smith & Nephew
5. B. Braun SE
6. Exactech Inc.
7. Globus Medical Inc.
8. Enovis Corporation
9. MicroPort Scientific Corporation
10. Meril Life

Trending Topics: Robotic-Assisted Hip Surgery, 3D-Printed Joint Implants, Revision Arthroplasty Solutions, Knee Reconstruction Devices, Shoulder Reconstruction Devices, Elbow Reconstruction Devices.

Global Headlines

• Zimmer Biomet announced FDA approval for iTaperloc Complete and iG7 Hip System – On October 28, 2025, Zimmer Biomet Holdings, Inc, a global medical technology leader, announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for iTaperloc Complete and iG7 Hip System, the company's first-to-world iodine-treated total hip replacement system.
• Exactech announced the launch of Spartan Stem and Logical Cup System – In August 2022, Exactech, a developer and producer of implants for joint replacement surgery, announced the launch of the Spartan™ Stem and Logical™ Cup System for total hip arthroplasty.

Conclusion

The global hip reconstruction devices market is set for sustained growth driven by rising osteoarthritis cases, hip fractures, and technological innovation. Increasing adoption of minimally invasive and robotic-assisted surgeries, coupled with expanding healthcare access in emerging economies, will continue to enhance surgical outcomes and market penetration worldwide.